|
In addition to the investment team, NLV
has assembled a team of industry professionals to serve on
an Industry Advisory Board. Each of these professionals have
unique experiences that complements the backgrounds of the
partners and adds value to many facets of our business,
including deal screening, portfolio company monitoring and
overall fund strategy. Below are the members of the NLV
Industry Advisory Board.
|
|
 |
-
Lee Babiss, Head, Global Pharma Research, Roche Pharmaceuticals, Inc.
-
Joseph Gray, Director of the Life Sciences Division, Department of Energy's Lawrence Berkeley National Laboratory
-
Peter Barton Hutt, Senior Counsel, Covington & Burling (specialty in Food and Drug Law)
-
Stephen Oesterle, M.D., Senior Vice President for Medicine and Technology, Medtronic, Inc.
-
Brian Seed, Ph.D, Professor of Genetics and Health Sciences & Technology, Harvard Medical School and Massachusetts General Hospital
-
Edward Skolnik, M.D., Norman S. Wikler Professor of Medicine and Professor of Pharmacology / Director, Division of Nephrology, New York University Medical Center
|
|